Cargando…
Surface Functionalised Parenteral Nanoemulsions for Active and Homotypic Targeting to Melanoma
Despite recent progressions in cancer genomic and immunotherapies, advanced melanoma still represents a life threat, pushing to optimise new targeted nanotechnology approaches for specific drug delivery to the tumour. To this aim, owing to their biocompatibility and favourable technological features...
Autores principales: | Foglietta, Federica, Bozza, Annalisa, Ferraris, Chiara, Cangemi, Luigi, Bordano, Valentina, Serpe, Loredana, Martina, Katia, Lazzarato, Loretta, Pizzimenti, Stefania, Grattarola, Margherita, Cucci, Marie Angele, Dianzani, Chiara, Battaglia, Luigi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10222029/ https://www.ncbi.nlm.nih.gov/pubmed/37242600 http://dx.doi.org/10.3390/pharmaceutics15051358 |
Ejemplares similares
-
Parenteral Nanoemulsions Loaded with Combined Immuno- and Chemo-Therapy for Melanoma Treatment
por: Monge, Chiara, et al.
Publicado: (2022) -
Nanoemulsions as Delivery Systems for Poly-Chemotherapy Aiming at Melanoma Treatment
por: Dianzani, Chiara, et al.
Publicado: (2020) -
Control of Oxidative Stress in Cancer Chemoresistance: Spotlight on Nrf2 Role
por: Barrera, Giuseppina, et al.
Publicado: (2021) -
Ultrasound-Responsive Nrf2-Targeting siRNA-Loaded Nanobubbles for Enhancing the Treatment of Melanoma
por: Argenziano, Monica, et al.
Publicado: (2022) -
Oxidative Stress-Related Mechanisms in Melanoma and in the Acquired Resistance to Targeted Therapies
por: Pizzimenti, Stefania, et al.
Publicado: (2021)